Title:
ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME
Document Type and Number:
WIPO Patent Application WO/2022/004859
Kind Code:
A1
Abstract:
Provided is a pharmaceutical composition for orally administering a pharmaceutical active ingredient which has a pH-dependent solubility profile, said pharmaceutical composition making it possible to achieve excellent scrubbing efficiency regardless of the pH inside the alimentary canal. Said oral pharmaceutical composition contains a pharmaceutical active ingredient which has a pH-dependent solubility profile, an inorganic or organic acid, and a hydrophilic polymer.
More Like This:
Inventors:
TANAKA AKIRA (JP)
FUNATANI CHIAKI (JP)
KURA KENICHI (JP)
KIMURA NAOKI (JP)
FUNATANI CHIAKI (JP)
KURA KENICHI (JP)
KIMURA NAOKI (JP)
Application Number:
PCT/JP2021/025019
Publication Date:
January 06, 2022
Filing Date:
July 01, 2021
Export Citation:
Assignee:
ARTHAM THERAPEUTICS INC (JP)
International Classes:
A61K9/10; A61K47/32; A61K9/16; A61K31/4439; A61K31/496; A61K31/517; A61K31/519; A61K31/5377; A61K31/553; A61K45/00; A61K47/02; A61K47/04; A61K47/12; A61K47/18; A61K47/22; A61K47/34; A61K47/38; A61P9/00; A61P35/00
Domestic Patent References:
| WO2016175230A1 | 2016-11-03 |
Foreign References:
| JP2019510059A | 2019-04-11 | |||
| JP2017002034A | 2017-01-05 | |||
| JP2009504796A | 2009-02-05 | |||
| JP2004518676A | 2004-06-24 | |||
| JP2009504795A | 2009-02-05 |
Other References:
PATEL CHIRAG G., RANGACHARI LAKSHMI, PATTI MARK, GRIFFIN CELINA, SHOU YAPING, VENKATAKRISHNAN KARTHIK: "Characterizing the Sources of Pharmacokinetic Variability for TAK-117 (Serabelisib), an Investigational Phosphoinositide 3-Kinase Alpha Inhibitor: A Clinical Biopharmaceutics Study to Inform Development Strategy", CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, vol. 8, no. 5, 1 July 2019 (2019-07-01), GB , pages 637 - 646, XP055897147, ISSN: 2160-763X, DOI: 10.1002/cpdd.613
C. PATEL , S. SANKOH , Y. SHOU , C. GRIFFIN , K. VENKATAKRISHNAN: "PII-110 Clinical biopharmaceutic assessments of the sources of absorption variability for the anticancer agent TAK-117, an inhibitor of phosphoinositide 3-kinase-a (PI3Kx)", CLINICAL PHARMACOLOGY AND THERAPEUTICS, vol. 101, no. S1, 1 February 2017 (2017-02-01), pages S82, XP055897162, ISSN: 1532-6535, DOI: 10.1002/cpt.570
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, vol. 8, no. 5, 2019, pages 637 - 646
CLINICAL CANCER RESEARCH, vol. 23, no. 17, 2017, pages 5218 - 5224
FDACENTER FOR DRUG EVALUATION AND RESEARCH, PRODUCT QUALITY REVIEW(S, 24 May 2019 (2019-05-24)
FDACENTER FOR DRUG EVALUATION AND RESEARCH, MULTI-DISCIPLINE
JURIC ET AL., CLIN. CANCER RES., vol. 23, no. 17, 2017, pages 5015 - 5023
PATEL ET AL., CLIN. PHARMACOL. DRUG DEV, vol. 8, no. 5, 2019, pages 637 - 646
UNIVERSITY OF THE SCIENCES: "Remington: The Science and Practice of Pharmacy", 2000, LIPPINCOTT WILLIAMS & WILKINS
PATEL ET AL., CLIN. PHARMACOL. DRUG DEV., vol. 8, no. 5, 2019, pages 637 - 646
C. PATEL , S. SANKOH , Y. SHOU , C. GRIFFIN , K. VENKATAKRISHNAN: "PII-110 Clinical biopharmaceutic assessments of the sources of absorption variability for the anticancer agent TAK-117, an inhibitor of phosphoinositide 3-kinase-a (PI3Kx)", CLINICAL PHARMACOLOGY AND THERAPEUTICS, vol. 101, no. S1, 1 February 2017 (2017-02-01), pages S82, XP055897162, ISSN: 1532-6535, DOI: 10.1002/cpt.570
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, vol. 8, no. 5, 2019, pages 637 - 646
CLINICAL CANCER RESEARCH, vol. 23, no. 17, 2017, pages 5218 - 5224
FDACENTER FOR DRUG EVALUATION AND RESEARCH, PRODUCT QUALITY REVIEW(S, 24 May 2019 (2019-05-24)
FDACENTER FOR DRUG EVALUATION AND RESEARCH, MULTI-DISCIPLINE
JURIC ET AL., CLIN. CANCER RES., vol. 23, no. 17, 2017, pages 5015 - 5023
PATEL ET AL., CLIN. PHARMACOL. DRUG DEV, vol. 8, no. 5, 2019, pages 637 - 646
UNIVERSITY OF THE SCIENCES: "Remington: The Science and Practice of Pharmacy", 2000, LIPPINCOTT WILLIAMS & WILKINS
PATEL ET AL., CLIN. PHARMACOL. DRUG DEV., vol. 8, no. 5, 2019, pages 637 - 646
Attorney, Agent or Firm:
AOKI, Atsushi et al. (JP)
Download PDF:
Previous Patent: TEXTILE FOR HOLLOW WEAVE AIRBAG
Next Patent: METHOD FOR PRODUCING LONG OPTICAL FILM CONTAINING POLYIMIDE RESIN
Next Patent: METHOD FOR PRODUCING LONG OPTICAL FILM CONTAINING POLYIMIDE RESIN